今天（11月8日） 2024粤港澳大湾区全球招商大会 在广州隆重召开The 2024 Global Investment Promotion Conference for the Guangdong-Hong Kong-Macao Greater ...

自2025年1月1日起，新加坡将实施新的企业税收政策，在新加坡开展业务或总部位于新加坡的大型跨国企业，其有效纳税率不得低于15%，此举是为了响应2024年财政预算案中宣布的税制变更，以及政策检讨中提出的相关调整。

Editor’s Note: Since the reform and opening-up, China has undergone profound transformations, with foreign multinational companies playing a key role. As important participants, they have provided ind ...

Editor’s Note: Since the reform and opening-up, China has undergone profound transformations, with foreign multinational ...

Anuruddha Rathninde, VP and President & APAC of Johnson Controls, expressed his optimism for aligning with China’s growth. He said, "As China's economy is growing, we want to make sure that we are ...

（原标题：Multinationals on China | President and CEO of Elekta: CIIE Empowers Elekta's Innovation in China） ...

总的来说，Trotman团队的这项研究成果表明，促氧化剂甲萘醌（维生素K3）可以通过抑制激酶VPS34的活性，破坏癌细胞的内吞，导致癌细胞发生独特的“triaptosis”死亡。这不仅意味着促氧化剂具有抗癌能力，而且还指出了一个治疗癌症的新方向，靶向 ...

“支持邂逅日间”系列专题将带领大家走进支持治疗的“前世”和“今生”，领略支持治疗的独特魅力。 “Supportive care（支持治疗）”这一术语起源于1987年2月召开的“International Symposium on Supportive ...

A series of partnerships were forged between multinational companies and state-owned enterprises in Pudong during the 7th ...

欧洲 – 荷兰医疗器械制造商飞利浦 (（Koninklijke Philips N.V.）)10月28日下调了年度销售预期，原因是中国需求下降，导致其第三季度订单量下降了 2%。 飞利浦目前预计 2024 年可比销售额将增长 0.5% 至 ...

Huangpu District announced a new trial policy aimed at increasing equity investment by multinational companies during its foreign investment promotion conference on Thursday.

迎接精准治疗的未来与挑战，解读ADC药物疗效与安全性的双重考量。抗体药物偶联物（ADC）作为近年来的抗肿瘤热门研究领域，其通过将单克隆抗体与细胞毒性药物结合，靶向肿瘤细胞并精准递送药物，从而实现了高效的抗癌治疗。2024年美国临床肿瘤学会（ASCO）年会上，众多ADC相关研究最新结果纷纷出炉，展现了其在肿瘤领域的应 ...